Skip to main content

Table 2 Descriptive results of RPI and competitor prices for the 30 highest volume insurance medicines before and after RPI introduction

From: Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan

Volume Rank*

Total # Claims

(RPI and Competitor)

Generic Medicine Name

(Brand Name)

Average Initial Price per Unit (SD) in Kyrgyz Som

Average Final Price per Unit (SD) in Kyrgyz Som

Competitor Price Change after RPI Introduction**

 

Before RPI Introduction

After RPI Introduction

 

Competitor

RPI

Competitor

RPI

 

1*

630

1,923

ampicillin 500 mg injection

7.6

(0.6)

6.0

(0.0)

7.7

(0.5)

6.0

(0.1)

+1.3%

2

0

494

amoxicillin 250 mg capsules

3.0***

(0.0)

2.5

(0.0)

3.0

(0.0)

2.5

(0.0)

0%

3*

467

1,138

benzylpenicillin 1 g injection

5.0

(0.0)

4.8

(0.2)

5.0

(0.0)

5.0

(0.2)

0%

4*

67

680

erythromycin 250 mg tablets

3.3

(0.2)

2.5

(0.0)

3.3

(0.4)

2.7

(0.0)

0%

5*

130

870

amoxicillin 250 mg tablets

3.0

(0.7)

2.6

(0.2)

2.8

(0.8)

2.5

(0.0)

-6.7%

6*

342

779

atenolol 50 mg tablets

1.6

(0.1)

1.1

(0.0)

0.9

(0.1)

0.9

(0.0)

-43.8%

7*

3

544

ciprofloxacin 250 mg tablets

4.3

(0.5)

2.4

(0.5)

3.5

(0.8)

2.8

(0.2)

-18.6%

8*

130

1,036

enalapril 20 mg tablets

(Ednyt®)

10.5

(1.0)

5.4

(0.0)

8.1

(0.5)

8.1

(1.0)

-22.9%

9*

515

760

metronidazole 250 m tablets

1.0

(0.2)

0.8

(0.0)

0.9

(0.0)

0.6

(0.1)

-10%

10*

5

226

ferrous sulfate+folic acid+ascorbic acid tablets

(Gyno-Tardyferon®)

3.8

(1.6)

8.2

(0.0)

8.2

(0.8)

8.2

(0.0)

+115.8%

11*

12

214

carbamazepine 200 mg tablets

1.9

(0.6)

2.0

(0.0)

1.5

(0.1)

1.4

(0.0)

-21.1%

12*

3

268

ferrous sulfate+ascorbic acid tablets

(Taryferon®)

2.7

(0.0)

7.3

(0.0)

8.7

(1.2)

7.3

(0.0)

+222.2%

13

43

314

enalapril 10 mg tablets

(Ednyt®)

6.9

(1.2)

5.1

(0.2)

5.0

(0.6)

5.2

(0.0)

-27.5%

14

150

429

co-trimoxazole 480 mg tablets

2.6

(0.3)

1.8

(0.0)

2.7

(0.3)

1.9

(0.0)

+3.8%

15

0

187

iron combination tablets

(Ferum Lek®)

6.4**

(1.0)

10.0

(0.0)

7.5

(1.9)

10.3

(1.3)

+17.2%

16*

53

209

nifedipine 20 mg retard tablets

(Corinafar Retard®)

3.3

(0.9)

3.6

(0.3)

3.7

(0.7)

5.0

(0.0)

+12.1%

17*

7

49

Prednisolone 5 mg tablets

1.1

(0.1)

1.3

(0.4)

0.5

(0.0)

0.9

(0.5)

-54.5%

18*

138

193

diclofenac 25 mg tablets

(Ortophen®)

0.7

(0.2)

0.4

(0.0)

0.6

(0.1)

0.6

(0.1)

-14.3%

19

114

197

ampicillin 250 mg tablets

1.9

(0.1)

1.4

(0.0)

1.5

(0.0)

1.6

(0.0)

-21.1%

20

484

395

co-trimoxazole 480 mg Tablets

(Biseptol®)

4.0

(0.0)

2.2

(0.0)

3.5

(0.0)

3.8

(0.0)

-12.50%

21

43

74

drotaverine 40 mg tablets

(No-Spa®)

2.4

(0.2)

2.3

(0.0)

2.5

(0.0)

2.6

(0.0)

+4.2%

22

28

110

metronidazole 250 mg tablets

(Trichopol®)

3.5

(0.4)

2.1

(0.0)

3.5

(0.0)

3.5

(0.0)

0%

23*

73

548

metronidazole 500 mg vaginal suppositories

11.9

(5.3)

5.2

(0.0)

6.5

(0.8)

6.0

(0.0)

-45.4%

24

13

60

ferrous sulfate+ascorbic acid drag

(Ferroplek®)

1.5

(0.5)

0.8

(0.0)

1.5

(0.0)

1.6

(0.0)

0%

25*

445

927

diclofenac 75 mg injection

8.1

(1.0)

3.9

(0.4)

6.0

(0.2)

5.3

(0.3)

-25.9%

26

140

226

bromhexine 8 mg tablets

0.5

(0.1)

0.3

(0.0)

0.4

(0.1)

0.6

(0.3)

-20%

27*

64

336

omeprazole 20 mg capsules

5.9

(0.5)

5.1

(0.6)

3.4

(1.0)

2.7

(0.0)

-42.4%

28*

70

113

ketotifen tablets

1.4

(0.3)

0.8

(0.0)

0.8

(0.0)

0.8

(0.0)

-42.9%

29*

269

216

doxycycline 100 mg capsules

2.8

(0.0)

1.3

(0.2)

1.0

(0.0)

1.5

(0.0)

-64.3%

30

3

56

verapamil 80 mg tablets

2.2

(0.5)

1.2

(0.0)

1.6

(0.0)

1.7

(0.0)

-27.3%

  1. *Used in time-series analyses
  2. **Difference in competitors' price from the quarter before the RPI was introduced to the end of the study period
  3. ***No price for quarter before RPI intro; this price from quarter where RPI price first appears
Back to article page

International Journal for Equity in Health

ISSN: 1475-9276

Contact us